Jack O'Neill Memorial Fund
In aid of research into Amyloidosis

In 2006, one of our colleagues, Jack O'Neill died aged 44 from a rare disease called Amyloidosis. After he was diagnosed, Jack was treated at the National Amyloidosis Centre in the Royal Free Hospital London which is both the only specialist treatment centre for patients in the UK and a leading research institute for the condition.

Howe Robinson, with the support of Jack's family, launched a memorial fund for Jack under the auspices of the UCL Amyloidosis Research Fund which itself operates under the umbrella of the UCL Development Fund, at University College London. Any money raised is applied directly to supporting the research work of the institute and will be appropriately acknowledged as having been given in Jack's memory.

The company set a target of £100,000 to be raised within the first 12 months and so far donations received total £75,000.

Further information about the disease and the work of the National Amyloidosis Centre can be viewed by clicking here.